Lopinavir 相關新聞

← 返回新聞總覽


Lopinavir 目前有 2 則相關新聞報導,預測適應症 20 個。

本頁整合 Lopinavir 的 AI 預測適應症與最新健康新聞,橘色標示的適應症表示近期有相關新聞報導。
藥物資訊
  • 原適應症:Lopinavir/ritonavir is indicated in combination with other antiretroviral medicinal products for the treatment of human immunodeficiency virus (HIV-1) infected adults, adolescents and children above...
  • 證據等級:L5
  • 預測適應症(20 個):
    • HIV infectious disease(100.0%)
    • simian immunodeficiency virus infection(99.9%)
    • feline acquired immunodeficiency syndrome(99.9%)
    • neurodevelopmental disorder with ataxic gait, absent speech, and decreased cortical white matter(99.9%)
    • AIDS(99.2%)
    • chronic hepatitis C virus infection(98.3%)
    • AIDS related complex(98.2%)
    • congenital human immunodeficiency virus(98.2%)
    • obsolete familial combined hyperlipidemia(95.2%)
    • hepatitis B virus infection(93.2%)
    • hepatitis C virus infection(88.3%)
    • fibroma of prostate(87.1%)
    • Brenner tumor(86.3%)
    • benign reproductive system neoplasm(86.2%)
    • benign prostate phyllodes tumor(85.6%)
    • hepatitis E virus infection(85.4%)
    • hepatitis, viral, animal(85.2%)
    • hepatitis A virus infection(85.0%)
    • Omsk hemorrhagic fever(84.8%)
    • Kyasanur forest disease(84.4%)

查看完整藥物報告 →

相關新聞(2 則)

Wirkstoff: Apilimod blockiert Viruseintritt in Leberzellen bei Hepatitis E

2026-04-27 hepatitis

來源:mt-portal.de


“Queremos aprovechar la experiencia de la estrategia frente a la hepatitis C para mejorar el abordaje global de la enfermedad hepática”

2026-04-26 hepatitis

來源:iSanidad


免責聲明:本頁新聞由系統自動收集,僅供研究參考,不構成醫療建議。

Copyright © 2026 EuTxGNN Project. For research purposes only. Not medical advice.

This site uses Just the Docs, a documentation theme for Jekyll.